March 04, 2015
The City of Providence is leading a putative class of consumers who accuse Celgene Corp. in a New Jersey federal suit filed Tuesday of monopolizing the market for two blockbuster cancer drugs by blocking competitors' access to samples needed to bring a generic to market.